Assessment of Early-detection Based on Liquid Biopsy in Lymphoid Malignancies

Exclusion Criteria

• •Insufficient qualified blood samples.
• •During pregnancy or lactation.
• •Recipient of organ transplant or prior non-autologous (allogeneic) bone marrow or stem cell transplant.
• •Recipient of blood transfusion within 7 days prior to blood draw.
• •Recipient of anti-tumor drugs to treat non-cancer diseases within 30 days prior to blood draw, such as rheumatic drugs (methotrexate, cyclophosphamide, or azathioprine), or endocrine drugs (tamoxifen).
• •With other known malignant tumors or multiple primary tumors.
• •Lymphoid malignancies unable to comfirmed by imaging tests or pathological cancer diagnosis within 42 days after the blood draw.
• •With other known malignant tumors or comfirmed lymphoid malignancies.
• •Lymphoid benign diseases unable to comfirmed by imaging tests or pathological cancer diagnosis within 42 days after the blood draw.